IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,117,000 | -93.5% | 48,409 | -97.3% | 0.00% | -95.7% |
| Q2 2020 | $63,316,000 | +761.9% | 1,786,596 | +227.8% | 0.02% | +666.7% |
| Q1 2020 | $7,346,000 | -32.8% | 544,965 | +5.5% | 0.00% | 0.0% |
| Q4 2019 | $10,931,000 | +50.5% | 516,592 | -5.7% | 0.00% | +50.0% |
| Q3 2019 | $7,264,000 | -4.4% | 547,817 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,599,000 | -18.4% | 547,817 | +13.0% | 0.00% | -33.3% |
| Q1 2019 | $9,314,000 | -39.1% | 484,850 | -34.0% | 0.00% | -40.0% |
| Q3 2018 | $15,303,000 | +45.1% | 734,673 | +64.9% | 0.01% | +66.7% |
| Q2 2018 | $10,546,000 | +122.7% | 445,551 | +37.4% | 0.00% | +50.0% |
| Q1 2018 | $4,736,000 | -46.6% | 324,181 | -40.9% | 0.00% | -33.3% |
| Q4 2017 | $8,871,000 | +1.5% | 548,943 | -12.2% | 0.00% | 0.0% |
| Q3 2017 | $8,743,000 | +173.8% | 625,402 | +73.0% | 0.00% | +200.0% |
| Q2 2017 | $3,193,000 | +63760.0% | 361,607 | +29014.9% | 0.00% | – |
| Q2 2015 | $5,000 | – | 1,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 4,373,178 | $371,851,000 | 55.73% |
| Avoro Capital Advisors LLC | 26,250,000 | $2,232,038,000 | 31.71% |
| Twin Securities, Inc. | 467,761 | $39,774,000 | 28.60% |
| Palo Alto Investors LP | 4,852,383 | $412,598,000 | 22.65% |
| Sand Grove Capital Management LLP | 470,000 | $39,964,000 | 21.19% |
| Beryl Capital Management LLC | 1,046,632 | $88,995,000 | 16.02% |
| Western Standard LLC | 158,065 | $13,440,000 | 15.26% |
| One68 Global Capital, LLC | 60,990 | $5,186,000 | 13.76% |
| First Light Asset Management, LLC | 1,577,880 | $134,167,000 | 13.75% |
| Boxer Capital, LLC | 4,500,000 | $382,635,000 | 13.22% |